ライフサイエンスコーパス: follicle-stimulating hormone

1 eptides derived from a proteolytic digest of follicle stimulating hormone.

2 cycle patterns or on elevated (>20 IU/liter) follicle-stimulating hormone.

3 but had no effect on luteinizing hormone or follicle-stimulating hormone.

4 volved in the response of gonadal tissues to follicle-stimulating hormone.

5 ), androstenedione, luteinizing hormone, and follicle-stimulating hormone.

6 iandrosterone sulfate, insulin, glucagon, or follicle-stimulating hormone after baseline hormone valu

7 Following superovulation with recombinant follicle-stimulating hormone and administration of gonad

8 Furthermore, an increase in follicle-stimulating hormone and decreases in testostero

9 mice and was associated with decreased serum follicle-stimulating hormone and higher claudin-11 expre

10 Concomitantly, the levels of follicle-stimulating hormone and IL-6 are increased 70 a

11 male mice do not feminize, and the levels of follicle-stimulating hormone and IL-6 are inhibited.

12 ted with a decrease in the concentrations of follicle-stimulating hormone and luteinising hormone, an

13 ll explore in detail effects on secretion of follicle-stimulating hormone and luteinising hormone.

14 higher body mass index (P = .05), and lower follicle-stimulating hormone and luteinizing hormone (ea

15 We measured follicle-stimulating hormone and luteinizing hormone and

16 Pituitary gonadotropins follicle-stimulating hormone and luteinizing hormone are

17 acterized by increasing dyssynchrony between follicle-stimulating hormone and luteinizing hormone in

18 fetime history of depression also had higher follicle-stimulating hormone and luteinizing hormone lev

19 The mean (SE) follicle-stimulating hormone and luteinizing hormone lev

20 ge in menopausal status, increased levels of follicle-stimulating hormone and luteinizing hormone, an

21 levels were elevated, as were the levels of follicle-stimulating hormone and luteinizing hormone.

22 We further found that WNT5a prevents follicle-stimulating hormone and luteinizing protein fro

23 hormone secretion and on pituitary hormone (follicle-stimulating hormone and prolactin), CgA, and Cg

24 iation into spermatozoa, whereas recombinant follicle-stimulating hormone and steroid hormones are in

25 imulatory actions of luteinizing hormone and follicle-stimulating hormone and to 17beta-estradiol and

26 Pituitary (luteinizing hormone and follicle-stimulating hormone) and uterine functions were

27 tosterone or estradiol, leutinizing hormone, follicle stimulating hormone, and prolactin were determi

28 Activin acts in the pituitary to stimulate follicle-stimulating hormone, and is antagonized by endo

29 one, and increased variability of estradiol, follicle-stimulating hormone, and luteinizing hormone ar

30 ned 12-month analysis evaluated E2, E1, E1S, follicle-stimulating hormone, and luteinizing hormone le

31 ns, gonadotropin-releasing hormone agonists, follicle-stimulating hormone, and luteinizing hormone.

32 the urinary forms of estrogen, progesterone, follicle-stimulating hormone, and luteinizing hormone.

33 ake, physical activity, luteinizing hormone, follicle-stimulating hormone, and progesterone.

34 estosterone, dehydroepiandrosterone sulfate, follicle-stimulating hormone, and sex hormone-binding gl

35 ome reaction as well as luteinizing hormone, follicle-stimulating hormone, and testosterone serum lev

36 ologic surgery, hormone replacement therapy, follicle-stimulating hormone, and vasomotor symptoms.

37 Follicle-stimulating hormone, anti-Mullerian hormone, an

38 1p14.1 SNP, rs11031006, in the region of the follicle-stimulating hormone B polypeptide (FSHB) gene s

39 ell as inhibin B dimers, necessary for local follicle-stimulating hormone beta regulation.

40 Within 2 h, follicle-stimulating hormone beta subunit (FSHbeta) mRNA

41 localizes to alpha-glycoprotein subunit- and follicle-stimulating hormone beta-positive cells of the

42 f pulses from the hypothalamus and regulates follicle-stimulating hormone beta-subunit (FSHbeta) gene

43 Two protein hormones (follicle-stimulating hormone beta-subunit and thyroid-st

44 ations with sex hormone-binding globulin and follicle-stimulating hormone (beta = -0.04, 95% confiden

45 Increased levels of follicle-stimulating hormone (beta = 0.20, 95% confidenc

46 and the gene was localized to within 3 cM of follicle-stimulating hormone, beta polypeptide in the mi

47 we report that exoloop 3 of FSH-R constrains follicle-stimulating hormone binding to the exodomain.

48 Activin stimulates whereas inhibin blocks follicle-stimulating hormone biosynthesis and secretion

49 irculating levels of luteinizing hormone and follicle-stimulating hormone but apparently normal respo

50 d in granulosa cells of growing follicles by follicle-stimulating hormone, but the highest levels of

51 gonadotropin, human luteinizing hormone, and follicle stimulating hormone by surface plasmon resonanc

52 ostic variables: age, body-mass index, basal follicle-stimulating hormone concentration, and the numb

53 for estradiol, the free estradiol index, or follicle-stimulating hormone concentrations.

54 its in testosterone, luteinizing hormone, or follicle-stimulating hormone concentrations.

55 Results for estradiol and follicle-stimulating hormone confirmed the results based

56 glycopeptides of equine and human pituitary follicle stimulating hormone (eFSH and hFSH) have been c

57 amples were assayed for luteinizing hormone, follicle-stimulating hormone, estradiol, and progesteron

58 t flashes, night sweats) and serum levels of follicle-stimulating hormone, estradiol, and sex hormone

59 corresponding serum luteinizing hormone and follicle-stimulating hormone fell progressively during t

60 mones from the hypothalamus, luteinizing and follicle stimulating hormones from the pituitary, and go

61 nadotropin hormones (luteinizing hormone and follicle-stimulating hormone) from the pituitary.

62 Follicle stimulating hormone (FSH) acts through receptor

63 a have implicated the pituitary gonadotropin follicle stimulating hormone (FSH) as both a risk factor

64 Follicle stimulating hormone (FSH) is a member of the gl

65 Follicle stimulating hormone (FSH) is one of the importa

66 hormone (ACTH), luteinizing hormone (LH) and follicle stimulating hormone (FSH) is preserved.

67 Leydig cell hyperproliferation and increased follicle stimulating hormone (FSH) levels.

68 Treatment of cultured Sertoli cells with follicle stimulating hormone (FSH) significantly increas

69 Activation of protein kinase A (PKA) by follicle stimulating hormone (FSH) transduces the signal

70 gonadotropins, luteinizing hormone (LH) and follicle stimulating hormone (FSH).

71 hormones, testosterone, androstenedione and follicle stimulating hormone (FSH).

72 ropic hormones, luteinizing hormone (LH) and follicle stimulating hormone (FSH).

73 lower estradiol, bioavailable estradiol, and follicle-stimulating hormone (FSH) (all p < 0.05) than w

74 Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) act on gonadal cells

75 ic protein-15 (BMP-15) can directly modulate follicle-stimulating hormone (FSH) action in rat granulo

76 Serum follicle-stimulating hormone (FSH) and E2 were measured

77 gulated at least in part by hormones such as follicle-stimulating hormone (FSH) and estrogen.

78 esumption of menses and serial monitoring of follicle-stimulating hormone (FSH) and inhibin A and B l

79 Although both the levels of follicle-stimulating hormone (FSH) and inhibin B are cor

80 Follicle-stimulating hormone (FSH) and luteinizing hormo

81 Undetectable or low levels of serum follicle-stimulating hormone (FSH) and luteinizing hormo

82 ght have an acute effect on the secretion of follicle-stimulating hormone (FSH) and luteinizing hormo

83 Leptin produced a dose-related increase in follicle-stimulating hormone (FSH) and luteinizing hormo

84 ole in reproductive physiology by regulating follicle-stimulating hormone (FSH) and luteinizing hormo

85 an inhibitor of prostaglandin signaling and follicle-stimulating hormone (FSH) and luteinizing hormo

86 ols the release of the gonadotropic hormones follicle-stimulating hormone (FSH) and luteinizing hormo

87 GnRH regulates the pituitary gonadotropin's follicle-stimulating hormone (FSH) and luteinizing hormo

88 ynthesis and secretion of the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormo

89 one, testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH) and sex hormone-bindi

90 Follicle-stimulating hormone (FSH) and syt-9 are highly

91 is Review, we briefly outline the roles that follicle-stimulating hormone (FSH) and testosterone play

92 Follicle-stimulating hormone (FSH) and the EGF-like pept

93 Multiple interactions exist between human follicle-stimulating hormone (FSH) and the N-terminal ho

94 Structure-function studies of follicle-stimulating hormone (FSH) and the other glycopr

95 We have also shown that follicle-stimulating hormone (FSH) can increase the expr

96 Follicle-stimulating hormone (FSH) comprises an alpha su

97 teinizing hormone (LH) secretion and that of follicle-stimulating hormone (FSH) could be valuable in

98 Follicle-stimulating hormone (FSH) glycosylation is regu

99 nses in the preceding 6 months and levels of follicle-stimulating hormone (FSH) in the postmenopausal

100 ts the beta-subunit of the pituitary hormone follicle-stimulating hormone (Fsh) increases bone mass i

101 We previously showed that follicle-stimulating hormone (FSH) induces the expressio

102 Follicle-stimulating hormone (FSH) is an essential regul

103 Follicle-stimulating hormone (FSH) is central to reprodu

104 Follicle-stimulating hormone (FSH) is in the family of p

105 Defined progesterone and follicle-stimulating hormone (FSH) levels were considere

106 ed whether all-trans-retinoic acid (tRA) and follicle-stimulating hormone (FSH) modulate RARalpha rec

107 mvent this problem, a genetically engineered follicle-stimulating hormone (FSH) mutant protein was pr

108 stis by conjugating Adjudin to a recombinant follicle-stimulating hormone (FSH) mutant, which serves

109 Studies-Depression Scale [CES-D Scale]) and follicle-stimulating hormone (FSH) plasma levels of depr

110 way, based on evidence that the GPCR agonist follicle-stimulating hormone (FSH) promotes the protein

111 lenge experiments to identify regions in the follicle-stimulating hormone (FSH) receptor (FSHR) ECD t

112 Follitropin, or follicle-stimulating hormone (FSH) receptor (FSHR), is a

113 ceptors are highly conserved, we mutated the follicle-stimulating hormone (FSH) receptor at the corre

114 The human follicle-stimulating hormone (FSH) receptor consists of

115 mely, BMP-15 promotes GC mitosis, suppresses follicle-stimulating hormone (FSH) receptor expression,

116 ependent of transcription, androgens enhance follicle-stimulating hormone (FSH) receptor expression,

117 In adult humans, the follicle-stimulating hormone (FSH) receptor is expressed

118 ught to elucidate the mechanism by which the follicle-stimulating hormone (FSH) receptor signals to p

119 hormone (LH)/chorionic gonadotropin (CG) or follicle-stimulating hormone (FSH) receptor, that at lea

120 Follicle-stimulating hormone (FSH) regulates follicular

121 there is a separate hypothalamic control of follicle-stimulating hormone (FSH) release distinct from

122 Regulation of follicle-stimulating hormone (FSH) synthesis is a centra

123 Although activins and inhibins regulate follicle-stimulating hormone (FSH) synthesis, no factor

124 ily protein hormones that suppress pituitary follicle-stimulating hormone (FSH) synthesis.

125 ycoprotein hormones, luteinizing hormone and follicle-stimulating hormone (FSH), act through their co

126 The gonadotropins, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and chorionic gonado

127 Baseline luteinizing hormone (LIT), follicle-stimulating hormone (FSH), and free-alpha-subun

128 serum level of antimullerian hormone (AMH), follicle-stimulating hormone (FSH), and inhibin B and ur

129 o direct the synthesis of the gonadotropins, follicle-stimulating hormone (FSH), and luteinizing horm

130 Measures of ovarian reserve were day-3 follicle-stimulating hormone (FSH), antral follicle coun

131 es undergo exponential growth in response to follicle-stimulating hormone (FSH), largely as a result

132 Fos family members in response to hormones (follicle-stimulating hormone (FSH), luteinizing hormone

133 tary, this innervation was observed close to follicle-stimulating hormone (FSH), luteinizing hormone

134 e sulfate (DHEAS), luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, fasting p

135 s 6-12 h after stimulation with forskolin or follicle-stimulating hormone (FSH), the major physiologi

136 iometry, and measurements of BNP, NT-proBNP, follicle-stimulating hormone (FSH), total testosterone,

137 cells to proliferate normally in response to follicle-stimulating hormone (FSH), whereas mutant males

138 vels of estradiol in women are controlled by follicle-stimulating hormone (FSH), which regulates tran

139 progesterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH), which were measured

140 phosphorylation, and thus, the expression of follicle-stimulating hormone (FSH)- and testosterone-ind

141 lial ovarian cancer nor its interaction with follicle-stimulating hormone (FSH)-driven proliferation

142 n, and importantly, the mitogenic effect was follicle-stimulating hormone (FSH)-independent.

143 ells (GCs) and produces a marked decrease in follicle-stimulating hormone (FSH)-induced progesterone

144 We sought to elucidate the role of AKT in follicle-stimulating hormone (FSH)-mediated granulosa ce

145 rized by amenorrhea and high serum levels of follicle-stimulating hormone (FSH).

146 y a ligand, epidermal growth factor (EGF) or follicle-stimulating hormone (FSH).

147 anulosa cells stimulated to differentiate by follicle-stimulating hormone (FSH).

148 double-null mice produce elevated levels of follicle-stimulating hormone (FSH).

149 beta-subunits of luteinizing hormone (LH) or follicle-stimulating hormone (FSH).

150 lls [expressing luteinizing hormone (LH) and follicle-stimulating hormone (FSH)], with adrenocorticom

151 as the premature ovarian failure (POF) rate (follicle-stimulating hormone [FSH] >/= 40 IU/L) after 1

152 The beta subunit of follicle stimulating hormone (FSHB) is expressed specifi

153 d that mice deficient in the beta-subunit of follicle-stimulating hormone (FSHbeta) are protected fro

154 pressing a glycoprotein hormone receptor for follicle-stimulating hormone (FSHR), CXC- (CXCR-2), and

155 , greater than 3 months of amenorrhea, and a follicle-stimulating hormone > or = 30 MIU/mL at the 12-

156 enstrual periods and serum concentrations of follicle-stimulating hormone >25 IU/L), meeting criteria

157 human chorionic gonadotropin (hCG) and human follicle-stimulating hormone had shown that it was possi

158 agment derived from the beta-domain of human Follicle-Stimulating Hormone (hFSH) are described.

159 een human choriogonadotropin (hCG) and human follicle-stimulating hormone (hFSH), but determinants of

160 and 651 enhance the internalization of human follicle-stimulating hormone (hFSH).

161 sary for embryonic development and pituitary follicle-stimulating hormone homeostasis, mice deficient

162 pausal status and in levels of estradiol and follicle-stimulating hormone in 2,659 women followed in

163 5+/-4.6 IU per liter (P<0.001), the level of follicle-stimulating hormone increased from 2.5+/-1.7 to

164 effects of recombinant BMP-4 and -7 on FSH (follicle-stimulating hormone)-induced rat granulosa cyto

165 family of small G-proteins is essential for follicle stimulating hormone-induced signaling events an

166 Body and testicular weight, testosterone, follicle-stimulating hormone level, and luteinizing horm

167 vaginal dryness (LR+ range, 1.48-3.79), high follicle-stimulating hormone levels (LR+ 3.06; 95% CI, 2

168 Serum follicle-stimulating hormone levels in the adult animals

169 with heavier menstrual bleeding, and higher follicle-stimulating hormone levels were associated with

170 tography and tandem mass spectrometry assay; follicle-stimulating hormone levels were measured at bas

171 , evaluated using anti-Mullerian hormone and follicle-stimulating hormone levels, was similar in both

172 tory findings (insulin-like growth factor 1, follicle-stimulating hormone, luteinizing hormone, and t

173 mong pituitary tumors, 30% (7/23), mainly in follicle-stimulating hormone/luteinizing hormone-produci

174 he transplantation in both patients by serum follicle-stimulating hormone measurements (patient A, 47

175 ment led to significant increases in CgB and follicle-stimulating hormone mRNAs in gonadotroph adenom

176 l Interview for DSM-IV, and plasma levels of follicle-stimulating hormone obtained at 3-6-month inter

177 sociated with a lower likelihood of elevated follicle-stimulating hormone (odds ratio (OR)=0.6, 95% c

178 before the FMP in the log rate of change of follicle-stimulating hormone (odds ratio, 0.65; 95% CI,

179 le development by attenuating the effects of follicle stimulating hormone on follicle growth and inhi

180 (-/-) cumulus cells do not respond to either follicle-stimulating hormone or IGF-I.

181 Serum levels of follicle-stimulating hormone (P=0.002) and luteinizing h

182 rmone release compared to KP10 and increased follicle-stimulating hormone plasma concentration.

183 adenomas, a gonadotroph luteinizing hormone/follicle-stimulating hormone-positive adenoma, exhibited

184 ed for individuals with a rapidly increasing follicle-stimulating hormone profile (P< or =.001) and a

185 icles, treatment with R-spondin2, similar to follicle stimulating hormone, promoted the development o

186 r ovarian stimulation with the letrozole and follicle-stimulating hormone protocol preserves fertilit

187 elical loops of luteinizing hormone receptor/follicle stimulating hormone receptor/thyroid stimulatin

188 The human follicle-stimulating hormone receptor (FSH-R) consists o

189 in reaction techniques for the evaluation of follicle-stimulating hormone receptor (FSHR) expression

190 The promoter for the rat follicle-stimulating hormone receptor (FSHR) gene contai

191 The luteinizing hormone receptor (LHR) and follicle-stimulating hormone receptor (FSHR) have an app

192 Follicle-stimulating hormone receptor (FSHR), a G-protei

193 les at the extracellular domain (ECD) of the follicle-stimulating hormone receptor (FSHR).

194 Human follicle-stimulating hormone receptor (hFSHR) belongs to

195 had a Sertoli cell appearance and expressed follicle-stimulating hormone receptor within the seminif

196 d the conserved serine in the LH (S277I) and follicle-stimulating hormone receptors (S273I) and obser

197 ot only are observed in regions that control follicle-stimulating hormone release but also are coloca

198 Additionally, A/C 46-78 decreased follicle-stimulating hormone release from the LbetaT2 ce

199 Follicle-stimulating hormone release was maximally inhib

200 er this peptide, known to selectively induce follicle-stimulating hormone release, is coexpressed in

201 e to TGF-beta with significant inhibition of follicle-stimulating hormone secretion at higher concent

202 entrations (10(-9) mol/L) and stimulation of follicle-stimulating hormone secretion at lower concentr

203 anscriptional activity and by suppression of follicle-stimulating hormone secretion by cultured anter

204 ding, activin transcriptional responses, and follicle-stimulating hormone secretion substantiates the

205 Increased luteinizing hormone relative to follicle-stimulating hormone secretion, insulin resistan

206 stradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, sex hormone-binding globul

207 Although follicles responded to initial follicle-stimulating hormone stimulation and developed n

208 onized the inhibitory effects of BMP4 on the follicle-stimulating hormone stimulation of progesterone

209 ta superfamily, is an important modulator of follicle-stimulating hormone synthesis and secretion in

210 ne (Tam-IVF) or in combination with low-dose follicle-stimulating hormone (TamFSH-IVF) or letrozole 5

211 amples were assayed for levels of estradiol, follicle-stimulating hormone, testosterone, and dehydroe

212 s do not support the use of urinary or blood follicle-stimulating hormone tests or antimullerian horm

213 Ratios of follicle stimulating hormone to luteinizing hormone, a s

214 combinant JY-1 protein regulates function of follicle-stimulating hormone-treated ovarian granulosa c

215 y end point was POF, defined as at least one follicle-stimulating hormone value of > 40 IU/L after 2

216 onths, and/or oophorectomy, and/or increased follicle-stimulating hormone values for reproductive-age

217 ng for the aromatase and the receptor of the follicle stimulating hormone were higher in contaminated

218 eir plasma levels of luteinizing hormone and follicle stimulating hormone were inappropriately low.

219 diol, progesterone, luteinizing hormone, and follicle-stimulating hormone were measured in serum up t

220 diol, progesterone, luteinizing hormone, and follicle-stimulating hormone were measured up to 8 times

221 sing hormone (GnRH) agonists and recombinant follicle-stimulating hormone were studied prospectively.

222 (human leutinizing hormone) and hFSH (human follicle stimulating hormone) were > 1 microM and approx

223 ost of patients (93%) had abnormal values of follicle-stimulating hormone, whereas the number of pati